All Stories

  1. Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing

    Article • HLA, May 2024, Wiley

    Maria Valeria Corrias

  2. From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models

    Article • Journal of Translational Medicine, February 2024, Springer Science + Business Media

    Maria Valeria Corrias

  3. Neuroblastoma is associated with alterations in gut microbiome composition subsequent to maternal microbial seeding

    Article • EBioMedicine, January 2024, Elsevier

    Maria Valeria Corrias

  4. Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma

    Article • Journal for ImmunoTherapy of Cancer, September 2023, BMJ

    Maria Valeria Corrias

  5. Maternal and food microbial sources shape the infant microbiome of a rural Ethiopian population

    Article • Current Biology, May 2023, Elsevier

    Maria Valeria Corrias

  6. The person-to-person transmission landscape of the gut and oral microbiomes

    Article • Nature, January 2023, Springer Science + Business Media

    Maria Valeria Corrias

  7. Nucleolin expression has prognostic value in neuroblastoma patients

    Article • EBioMedicine, November 2022, Elsevier

    Maria Valeria Corrias

  8. Recent advances in the developmental origin of neuroblastoma: an overview

    Article • Journal of Experimental & Clinical Cancer Research, March 2022, Springer Science + Business Media

    Maria Valeria Corrias

  9. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature

    Article • Pediatric Hematology and Oncology, February 2022, Taylor & Francis

    Maria Valeria Corrias

  10. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma

    Article • Cancers, November 2021, MDPI AG

    Maria Valeria Corrias

  11. Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors

    Article • Pharmaceuticals, August 2021, MDPI AG

    Maria Valeria Corrias

  12. The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis

    Article • Nutrients, June 2021, MDPI AG

    Maria Valeria Corrias

  13. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

    Article • Journal of Experimental & Clinical Cancer Research, June 2021, Springer Science + Business Media

    Maria Valeria Corrias

  14. Bone Marrow Environment in Metastatic Neuroblastoma

    Article • Cancers, May 2021, MDPI AG

    Maria Valeria Corrias

  15. Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma

    Article • Journal of Personalized Medicine, February 2021, MDPI AG

    Maria Valeria Corrias

  16. Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry

    Article • Pediatric Blood & Cancer, January 2021, Wiley

    Maria Valeria Corrias

  17. Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models

    Article • Small, April 2020, Wiley

    Maria Valeria Corrias

  18. Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

    Article • Journal of Cellular and Molecular Medicine, February 2020, Wiley

    Maria Valeria Corrias

  19. Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study ‖

    Article • Cancers, September 2019, MDPI AG

    Maria Valeria Corrias

  20. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene

    Article • Carcinogenesis, September 2019, Oxford University Press (OUP)

    Maria Valeria Corrias

  21. Plasma free metanephrines for diagnosis of neuroblastoma patients

    Article • Clinical Biochemistry, April 2019, Elsevier

    Maria Valeria Corrias

  22. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia

    Article • BMC Medical Genetics, February 2019, Springer Science + Business Media

    Maria Valeria Corrias

  23. Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells

    Article • OncoImmunology, February 2019, Taylor & Francis

    Alberto Horenstein, Maria Valeria Corrias

  24. Effects of Imatinib mesylate in subjects with relapsed/refractory neuroblastoma

    Article • OncoImmunology, June 2018, Taylor & Francis

    Maria Valeria Corrias

  25. miRNA expression profile of bone marrow resident cells from children with neuroblastoma is not significantly different from that of healthy children

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Maria Valeria Corrias

  26. Event‐free survival of infants and toddlers enrolled in the HR‐NBL‐1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

    Article • Pediatric Blood & Cancer, March 2018, Wiley

    Maria Valeria Corrias

  27. Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma

    Article • Scientific Reports, October 2017, Springer Science + Business Media

    Maria Valeria Corrias

  28. Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages

    Article • The Journal of Immunology, August 2017, Oxford University Press (OUP)

    Maria Valeria Corrias

  29. Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma

    Article • Oncotarget, May 2017, Impact Journals, LLC

    Maria Valeria Corrias

  30. CD4+CD25hiCD127− Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastoma

    Article • OncoImmunology, October 2016, Taylor & Francis

    Maria Valeria Corrias

  31. Soluble HLA-G and HLA-E Levels in Bone Marrow Plasma Samples Are Related to Disease Stage in Neuroblastoma Patients

    Article • Journal of Immunology Research, January 2016, Hindawi Publishing Corporation

    Maria Valeria Corrias

  32. PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance

    Article • OncoImmunology, July 2015, Taylor & Francis

    Maria Valeria Corrias

  33. Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients

    Article • Oncotarget, April 2015, Impact Journals, LLC

    Maria Valeria Corrias

  34. New Immunotherapeutic Strategies for the Treatment of Neuroblastoma

    Article • Immunotherapy, March 2015, Taylor & Francis

    Maria Valeria Corrias

  35. Expression ofFOXP3,CD14, andARG1in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Maria Valeria Corrias

  36. IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Maria Valeria Corrias

  37. Evaluation of bone marrow as a metastatic site of human neuroblastoma

    Article • Annals of the New York Academy of Sciences, October 2014, Wiley

    Maria Valeria Corrias

  38. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma

    Article • Leukemia, October 2014, Springer Science + Business Media

    Claudio Tripodo, Maria Valeria Corrias

  39. Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study

    Article • Journal of Clinical Oncology, April 2014, American Society of Clinical Oncology (ASCO)

    Maria Valeria Corrias

  40. Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity

    Article • Medical Oncology, March 2014, Springer Science + Business Media

    Maria Valeria Corrias

  41. Seasonal variations of date of diagnosis and birth for neuroblastoma patients in Italy

    Article • Cancer Epidemiology, October 2013, Elsevier

    Dr Riccardo Haupt, Maria Valeria Corrias

  42. Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells

    Article • The Journal of Immunology, May 2013, Oxford University Press (OUP)

    Maria Valeria Corrias

  43. Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma

    Article • Annals of Oncology, May 2013, Elsevier

    Maria Valeria Corrias

  44. Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Maria Valeria Corrias

  45. Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma

    Article • OncoTargets and Therapy, November 2012, Taylor & Francis

    Dr Riccardo Haupt, Paolo D'Angelo, Maria Valeria Corrias

  46. Restricted ROC curves are useful tools to evaluate the performance of tumour markers

    Article • Statistical Methods in Medical Research, June 2012, SAGE Publications

    Maria Valeria Corrias

  47. Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling

    Article • Analytical Biochemistry, February 2012, Elsevier

    Maria Valeria Corrias

  48. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature

    Article • Pediatric Blood & Cancer, October 2011, Wiley

    Maria Valeria Corrias

  49. Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients

    Article • Medical Oncology, June 2011, Springer Science + Business Media

    Maria Valeria Corrias

  50. Why Do Cancer Omics Attract Clinicians So Much?

    Article • OMICS A Journal of Integrative Biology, March 2011, Mary Ann Liebert Inc

    Maria Valeria Corrias

  51. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors

    Article • Pediatric Blood & Cancer, January 2011, Wiley

    Dr Riccardo Haupt, Maria Valeria Corrias

  52. Neuroblastoma and bone metastases: Clinical significance and prognostic value of Dickkopf 1 plasma levels

    Article • Bone, January 2011, Elsevier

    Maria Valeria Corrias

  53. Transient depletion of CD4+ T cells augments IL‐21‐based immunotherapy of disseminated neuroblastoma in syngeneic mice

    Article • International Journal of Cancer, June 2010, Wiley

    Maria Valeria Corrias

  54. Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA

    Article • Pediatric Blood & Cancer, January 2010, Wiley

    Dr Riccardo Haupt, Maria Valeria Corrias

  55. Chemokines in neuroectodermal tumour progression and metastasis

    Article • Seminars in Cancer Biology, April 2009, Elsevier

    Maria Valeria Corrias

  56. Umbilical Cord Blood Transplantation: Should Perinatal Solid Cancer Become a Matter of Concern?

    Article • JNCI Journal of the National Cancer Institute, December 2008, Oxford University Press (OUP)

    Maria Valeria Corrias

  57. Minimal disease monitoring by QRT–PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials

    Article • The Journal of Pathology, August 2008, Wiley

    Maria Valeria Corrias

  58. Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7‐H3 surface molecule

    Article • Histopathology, June 2008, Wiley

    Maria Valeria Corrias

  59. Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen

    Article • Medical Oncology, March 2008, Springer Science + Business Media

    Maria Valeria Corrias

  60. Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

    Article • British Journal of Cancer, January 2008, Springer Science + Business Media

    Maria Valeria Corrias

  61. Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice

    Article • Medical Oncology, April 2007, Springer Science + Business Media

    Maria Valeria Corrias

  62. Tumor Origin of Endothelial Cells in Human Neuroblastoma

    Article • Journal of Clinical Oncology, February 2007, American Society of Clinical Oncology (ASCO)

    Maria Valeria Corrias

  63. Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET

    Article • European Journal of Cancer, January 2007, Elsevier

    Maria Valeria Corrias

  64. Peripheral Blood Stem Cell Tumor Cell Contamination and Survival of Neuroblastoma Patients

    Article • Clinical Cancer Research, October 2006, American Association for Cancer Research (AACR)

    Maria Valeria Corrias

  65. Effect of Bortezomib on Human Neuroblastoma Cell Growth, Apoptosis, and Angiogenesis

    Article • JNCI Journal of the National Cancer Institute, August 2006, Oxford University Press (OUP)

    Maria Valeria Corrias

  66. Diagnostic identification of malignant cells in the cerebrospinal fluid by tumor-specific qRT-PCR

    Article • Clinical & Experimental Metastasis, June 2006, Springer Science + Business Media

    Maria Valeria Corrias

  67. Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ

    Article • British Journal of Cancer, May 2006, Springer Science + Business Media

    Maria Valeria Corrias

  68. Comparison of different techniques and markers in the detection of neuroblastoma cells in bone marrow and peripheral blood samples: are they really equivalent?

    Article • Targeted Oncology, April 2006, Springer Science + Business Media

    Maria Valeria Corrias

  69. CXCL12 Does Not Attract CXCR4+ Human Metastatic Neuroblastoma Cells: Clinical Implications

    Article • Clinical Cancer Research, January 2006, American Association for Cancer Research (AACR)

    Maria Valeria Corrias

  70. Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells

    Article • Cancer Research, December 2004, American Association for Cancer Research (AACR)

    Maria Valeria Corrias

  71. Detection of Neuroblastoma Cells in Bone Marrow and Peripheral Blood by Different Techniques

    Article • Clinical Cancer Research, December 2004, American Association for Cancer Research (AACR)

    Maria Valeria Corrias

  72. Immunogenicity of Human Neuroblastoma

    Article • Annals of the New York Academy of Sciences, December 2004, Wiley

    Maria Valeria Corrias

  73. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis

    Article • Proceedings of the National Academy of Sciences, August 2004, Proceedings of the National Academy of Sciences

    Maria Valeria Corrias

  74. Low-dose interferon-γ-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity

    Article • British Journal of Cancer, May 2004, Springer Science + Business Media

    Maria Valeria Corrias

  75. Different levels of control prevent interferon-γ-inducible HLA-class II expression in human neuroblastoma cells

    Article • Oncogene, October 2003, Springer Science + Business Media

    MD, PhD Roberto S Accolla, Maria Valeria Corrias

  76. Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments

    Article • Cancer Letters, July 2003, Elsevier

    Maria Valeria Corrias

  77. Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L

    Article • British Journal of Cancer, May 2003, Springer Science + Business Media

    Maria Valeria Corrias

  78. Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progression

    Article • Medical Oncology, February 2003, Springer Science + Business Media

    Maria Valeria Corrias

  79. A novel syngeneic murine model for thoracic neuroblastoma obtained by intramediastinal injection of tumor cells

    Article • Cancer Detection and Prevention, December 2002, Elsevier

    Maria Valeria Corrias

  80. Lack of HLA‐class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression

    Article • Tissue Antigens, February 2001, Wiley

    Maria Valeria Corrias

  81. Full Cytogenetic Characterization of a New Neuroblastoma Cell Line with a Complex 17q Translocation

    Article • Cancer Genetics and Cytogenetics, January 2000, Elsevier

    Maria Valeria Corrias

  82. Article • Journal of Neuro-Oncology, January 1997, Springer Science + Business Media

    Maria Valeria Corrias

  83. Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma

    Article • International Journal of Cancer, October 1996, Wiley

    Maria Valeria Corrias

  84. Induction of 2,5 oas gene expression and activity is not sufficient for IFN‐γ‐induced neuroblastoma cell differentiation

    Article • International Journal of Cancer, July 1995, Wiley

    Maria Valeria Corrias

  85. Synergistic Differentiation-Promoting Activity of Interferon   and Tumor Necrosis Factor- : Role of Receptor Regulation on Human Neuroblasts

    Article • JNCI Journal of the National Cancer Institute, November 1994, Oxford University Press (OUP)

    Maria Valeria Corrias

  86. Cloning and sequencing of isoform-specific regions of human Ca2+ -independent protein kinase C (PKC)-encoding genes

    Article • Gene, April 1994, Elsevier

    Maria Valeria Corrias

  87. Uncoordinate induction and differential regulation of hla class‐I and class‐II expression by γ‐interferon in differentiating human neuroblastoma cells

    Article • International Journal of Cancer, November 1993, Wiley

    Maria Valeria Corrias

  88. Protein kinase C isoenzymes in human neuroblasts involvement of PKCε in cell differentiation

    Article • FEBS Letters, May 1993, Wiley

    Maria Valeria Corrias

  89. A new peptide analog (RM06) modulates the growth of hematopoietic cells

    Article • International Journal of Immunopharmacology, January 1991, Elsevier

    Maria Valeria Corrias

  90. Expression of a gene for mouse eucaryotic elongation factor Tu during murine erythroleukemic cell differentiation.

    Article • Molecular and Cellular Biology, November 1987, ASM Journals

    Maria Valeria Corrias